DCF — ST MARYS MEDICAL CENTER
Enterprise Value: $-113.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-113.9M
Enterprise Value
$-36.3M
PV of Cash Flows
$-77.6M
PV of Terminal Value
$-124.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $79.8M | $-6.9M | -9.0% | $-10.3M | $-9.4M |
| Year 2 | $82.2M | $-6.3M | -8.0% | $-9.8M | $-8.1M |
| Year 3 | $84.6M | $-5.7M | -7.0% | $-9.3M | $-7.0M |
| Year 4 | $87.2M | $-5.4M | -6.0% | $-9.1M | $-6.2M |
| Year 5 | $89.8M | $-5.3M | -6.0% | $-9.1M | $-5.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-113.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$77.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09199761567067075
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5